Testing effectiveness (Phase 2)Study completedNCT00389441What this trial is testingStudy Of AG-013736 In Patients With 131I-Refractory Thyroid CancerWho this might be right forThyroid Neoplasms Pfizer 52
Testing effectiveness (Phase 2)Study completedNCT00519896What this trial is testingSunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid CancerWho this might be right forRecurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+5 more University of Washington 35
Testing effectiveness (Phase 2)Study completedNCT02614495What this trial is testingStudy of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid CarcinomaWho this might be right forThyroid Carcinoma Hutchison Medipharma Limited 66
Early research (Phase 1)Active Not RecruitingNCT05241834What this trial is testingLOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to TreatmentWho this might be right forCarcinoma, Non-Small-Cell LungThyroid Neoplasms Eli Lilly and Company 70
Not applicableStudy completedNCT05507775What this trial is testingDigoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid CarcinomaWho this might be right forNon-Medullary Thyroid Carcinoma Radboud University Medical Center 8
Testing effectiveness (Phase 2)Study completedNCT02601950What this trial is testingTazemetostat in Adult Participants With Soft Tissue SarcomaWho this might be right forMalignant Rhabdoid Tumors (MRT)Rhabdoid Tumors of the Kidney (RTK)Atypical Teratoid Rhabdoid Tumors (ATRT)+8 more Epizyme, Inc. 267
Early research (Phase 1)Ended earlyNCT00002947What this trial is testingIndium In 111 Pentetreotide in Treating Patients With Refractory CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more Yale University 35
Not applicableActive Not RecruitingNCT04970134What this trial is testingSpanish Study for Molecular Characterization of Thyroid CarcinomaWho this might be right forDifferentiated Thyroid CarcinomaMedullary Thyroid Carcinoma Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 150
Early research (Phase 1)Active Not RecruitingNCT04514484What this trial is testingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVWho this might be right forAdvanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more National Cancer Institute (NCI) 8
Early research (Phase 1)Study completedNCT01709435What this trial is testingCabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid TumorsWho this might be right forRecurrent Malignant Solid NeoplasmRecurrent MelanomaRecurrent Primary Central Nervous System Neoplasm+4 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT05286801What this trial is testingTiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient TumorsWho this might be right forAtypical Teratoid/Rhabdoid TumorEpithelioid SarcomaKidney Medullary Carcinoma+15 more National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Study completedNCT00098813What this trial is testingRomidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive IodineWho this might be right forRecurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592What this trial is testingCabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare TumorsWho this might be right forAdrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more National Cancer Institute (NCI) 109
Testing effectiveness (Phase 2)Study completedNCT01270321What this trial is testingPasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid CancerWho this might be right forThyroid Cancer Emory University 42
Testing effectiveness (Phase 2)Study completedNCT00026533What this trial is testingThalidomide in Treating Patients With Thyroid CancerWho this might be right forHead and Neck Cancer Kenneth Ain
Testing effectiveness (Phase 2)Study completedNCT00381641What this trial is testingSunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryWho this might be right forDifferentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaRefractory Thyroid Gland Carcinoma+16 more National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Study completedNCT00027820What this trial is testingTotal-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAdult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more Fred Hutchinson Cancer Center 106